Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
14q12 Microdeletion Syndrome C4305240
A rare chromosomal condition where a segment of chromosome 14 is missing. It may cause developmental delays and other health concerns. Treatment is supportive and individualized.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a feature; severity and domains are not specified. | May occur; timing and domains are not specified. | Low |
| Growth concerns | Growth issues are mentioned, without defined measurements. | Not specifically established in the supplied description. | Moderate |
| Age at recognition | Onset is labeled variable. | Onset is labeled 0–1 year. | Moderate |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
Chromosomal testing shows a 1q24q25 deletion
The genomic location supports this diagnosis over a chromosome 14 deletion.
High
Growth issues accompany developmental delay
Growth concerns are specifically mentioned for the left condition, but do not prove it.
Low
Clinician assigns a severe congenital phenotype
The source labels severity as severe; clinical confirmation is still required.
Low
Choose 14q12 Microdeletion Syndrome C4305240 when
Testing identifies a 14q12 deletion
The chromosome and band distinguish it from a 1q24q25 deletion.
High
Concerns begin in infancy
The supplied onset is 0–1 year, although overlap remains possible.
Moderate
Phenotype is judged moderate
The source severity label is moderate, but individual findings vary.
Low
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect deletion involving 1q24q25. | May detect deletion involving 14q12. | Genomic location is the main distinction; clinician and laboratory review are required. |
| Karyotype | May miss a small deletion. | May miss a small deletion. | A normal karyotype does not exclude either microdeletion. |
| Growth assessment | Growth issues are reported, without cutoffs here. | No specific growth pattern is established here. | Measurements support care but do not diagnose either syndrome. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Chronic course labeled severe; individual outcome is not established.
- Factors
- Deletion findings, growth issues, developmental needs, and associated medical concerns.
14q12 Microdeletion Syndrome C4305240
- Outcome
- Chronic course labeled moderate; individual outcome is not established.
- Factors
- Deletion findings, developmental needs, and any associated health concerns.
Time frame: From recognition through long-term follow-up; left onset variable, right often infancy.
Precise prognosis, mortality, and response cannot be inferred from these sparse data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delays are described; extent is unspecified. Delays may occur; extent is unspecified. Both may need developmental surveillance. |
| Growth or medical concerns | Growth issues and various concerns are mentioned. Other health concerns are possible but unspecified. No complication rates are established in the source. |
| Long-term course | Labeled chronic and severe. Labeled chronic and moderate. These labels do not predict an individual outcome. |
Patient education highlights
- HighDiagnosis
Only chromosomal testing interpreted by specialists can distinguish these deletions.
- HighCare
Treatment is supportive and tailored to each person’s findings, not a single regimen.
- MediumInheritance and spread
Neither condition is communicable; recurrence counseling requires genetics review.